Haematology research is vital for us to understand more about the conditions that affect our patients. Research provides unique opportunities for patients to receive novel therapies and enables all of us to be a part of the discovery of greater knowledge that will fuel progress in this field.
By participating in clinical research you are making a valuable contribution towards understanding and finding new treatment for rare non-malignant haematologic diseases.
Neurological Complications of Thrombotic Thrombocytopenic Purpura.
Reduced dose versus full dose Apixaban in Cancer Associated Thrombosis.
Nipocalimab for the treatment of Warm Autoimmune Haemolytic Anaemia.
Rare Diseases Registry.
A Phase 2a, double-blind, randomised, placebo-controlled, efficacy, and safety study of multiple doses of VIT-2763 in subjects with sickle cell disease.
Use of Fostamatinib in Adult Patients with Chronic Immune Thrombocytopenia (cITP) who are Refractory to Previous Treatments.